帕洛诺司琼预防老年肺癌化疗后恶心呕吐的疗效观察(3)
![]() |
第1页 |
参见附件。
[3]Geling O,Eichler HG.Should 5-hydroxytryptamine-3 receptor antagonists be administered Beyond 24 hours after chemotherpy to prevent delayed emesis systemic re-evaluation of clinical evidence and drug cost implications[J]. J Clin Oncol,2005,23(6):1289-1294.
[4]Rojas C, Stathis M, Alt J, et al. Additional binding mechanism of palonosetron to the 5-HT3 receptor versus first generation 5-HT3 receptor antagonists[J]. J Clin Oncol, 2007, 25(18S):713.
[5]Rojas C,Thomas AG, Alt J,et a1.Palonosetron triggers 5-Ht3 receptor internalization and cause prolonged inhibition of receptor function[J] ......
您现在查看是摘要介绍页,详见PDF附件。